Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $40
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Eva Fortea Verdejo maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $35 to $40.
Wells Fargo analyst Eva Fortea Verdejo maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $35 to $40.